García-Quintana, Antonio
Alonso Ramos, Héctor
Parrondo, Javier
Funding for this research was provided by:
Novartis Pharmaceuticals
This article is maintained by: Elsevier
Article Title: Coste-utilidad de sacubitrilo/valsartán en insuficiencia cardiaca con fracción de eyección reducida en España
Journal Title: Farmacia Hospitalaria
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.04.004
Content Type: article
Copyright: © 2025 The Author(s). Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Farmacia Hospitalaria (S.E.F.H).